Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors

Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors

(1) Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) penetrates respiratory epithelium through angiotensin-converting enzyme-2 binding, raising concerns about the potentially harmful effects of renin–angiotensin system inhibitors (RASi) on Human Coronavirus Disease 2019 (COVI...

Full description

Bibliographic Details
Main Authors: Elena-Mihaela Cordeanu, Lucas Jambert, Francois Severac, Hélène Lambach, Jonathan Tousch, Marie Heitz, Corina Mirea, Amer Hamadé, Waël Younes, Anne-Sophie Frantz, Hamid Merdji, Valérie Schini-Kerth, Pascal Bilbault, Ferhat Meziani, Patrick Ohlmann, Emmanuel Andres, Dominique Stephan
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
SARS-CoV-2
renin–angiotensin system inhibitor
angiotensin-converting enzyme
angiotensin II receptor blocker
propensity score
Online Access:https://www.mdpi.com/2077-0383/9/11/3472

Internet

https://www.mdpi.com/2077-0383/9/11/3472

Similar Items